Select the type of procedure
21124917
1
Enquiry period
with
30.11.2023 15:02
to 04.12.2023 16:00
to 04.12.2023 16:00
2
Bidding period
with
04.12.2023 16:00
to 08.12.2023 10:00
to 08.12.2023 10:00
3
Auction
11.12.2023 14:00
4
Evaluation
5
Contract
Status
Evaluation
Estimated value without VAT
35 500 MDL
Period of clarifications:
30 Nov 2023, 15:02 - 4 Dec 2023, 16:00
Submission of proposals:
4 Dec 2023, 16:00 - 8 Dec 2023, 10:00
Supplier technical support:
(+373) 79999801
Subscribe impossible
during the period Evaluation
Achiziționarea medicamentului Aciclovirum, 250 mg, Pulb./sol. perf. necesar IMSP suplimentar pentru anul 2023
Information about customer
Fiscal code/IDNO
Address
MD-2009, MOLDOVA, mun.Chişinău, locality, MD-2009, Republica Moldova, Chişinău str. Cosmescu 3
Web site
---
The contact person
Purchase data
Date created
30 Nov 2023, 14:56
Date modified
30 Nov 2023, 15:02
Achizitii.md ID
21124917
MTender ID
CPV
33600000-6 - Produse farmaceutice
Type of procedure
Request price offers (goods)
Award criteria
The lowest price
Funding sources
List of lots
Documents of the procurement procedure
Scrisoare de garantie bancara_Model
Bidding Documents
Scrisoare de garantie bancara_Model
30.11.23 15:02
Lista de distributie_Aciclovir 250 mg Pulb._sol. perf.
Bidding Documents
Lista de distributie_Aciclovir 250 mg Pulb._sol. perf.
30.11.23 15:02
Model contract_Aciclovirum 250 mg Pulb_sol. perf. pu 2023
Bidding Documents
Model contract_Aciclovirum 250 mg Pulb_sol. perf. pu 2023
30.11.23 15:02
Declaratie privind valabilitatea ofertei_Model
Bidding Documents
Declaratie privind valabilitatea ofertei_Model
30.11.23 15:02
Anunt de participare_30.11.2023.signed
Bidding Documents
Anunt de participare_30.11.2023
30.11.23 15:02
Declaratie beneficiari efectivi_Model
Bidding Documents
Declaratie beneficiari efectivi_Model
30.11.23 15:02
Documentatia standard_30.11.2023.signed
Bidding Documents
Documentatia standard_30.11.2023
30.11.23 15:02
Only authorized platform users may ask questions during the clarification period.
Document successfully signed
OK